Form 4 for BCTX BriaCell Therapeutics Corp.
Accepted 2022-12-28 00:00:00 ET · period of report 2022-12-28 · accession 0001493152-22-036669 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-28 | 2022-12-28 | BCTX | Bondarenko Jamieson | COB, Dir | P - Purchase | $4.58 | +28.0K | 169.9K | +20% | +$128.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-12-28 | P | A | 28,000 | $4.58 | 169,856 | D | — | — |